L’Occitane Sells Elemis to PAI Partners as Sales Top USD 300 Million

In this article (7)
L’Occitane Group agreed to sell British skincare brand Elemis to French private equity firm PAI Partners after net sales at the label topped USD 300 million. The companies announced the agreement on November 4 without disclosing financial terms.
Regulatory approvals will determine the closing timeline, scheduled for the first quarter of 2027. The divestment unwinds the largest acquisition in L’Occitane’s history, completed in 2019 under billionaire owner Reinold Geiger for USD 900 million.
Seven Years of Expansion
Elemis almost doubled its net sales during its seven years inside the French personal care group. Online platforms generate nearly half of its sales, while the United States accounts for roughly half of its total business.
Geiger bought out minority shareholders and delisted L’Occitane from the Hong Kong Stock Exchange in 2024, ending a 14-year run on the Asian bourse that began in 2010. The group generated EUR 2.8 billion in global net sales for the fiscal year ended March 31, 2025, up 12 per cent year-on-year at constant exchange rates.
“This transaction reflects a disciplined portfolio decision, focused on creating long-term value for the Group,” he said.
Refocusing Capital After Hong Kong Delisting
L’Occitane spent years pitching its dual French heritage and Asian retail footprint to investors in Hong Kong. Offloading Elemis frees up balance sheet capacity for the group’s faster-growing fragrance and body care divisions, led by Sol de Janeiro alongside Erborian, Melvita and flagship L’Occitane en Provence.
Rival multi-brand conglomerates across Asia have similarly pulled back from bloated brand rosters. Operators in department stores and travel retail hubs must now prepare for PAI to pivot Elemis distribution toward standalone retail and digital channels in Western markets, reallocating counter space that previously leaned on L’Occitane’s corporate muscle.
Private Equity Direction
PAI partners Gaëlle d’Engremont and Colm O’Sullivan said their operational priorities centre on expanding digital commerce and pushing further into the United States while retaining the brand’s British positioning. Elemis was established in 1989 and built its early trade through spas and salon networks.
Scrutiny now turns to the regulatory clearance process leading into the targeted first-quarter 2027 closing date. Retail investors will watch whether L’Occitane uses the proceeds to retire debt from its 2024 take-private buyout or reinvest in its remaining Asian skincare assets.
Questions & Answers
Q.Why is L’Occitane selling Elemis after doubling the brand's sales?
Why is L’Occitane selling Elemis after doubling the brand's sales?
The divestment allows L’Occitane to free up balance sheet capacity and refocus capital on faster-growing fragrance and body care divisions, such as Sol de Janeiro, Erborian and Melvita, following the company's delisting from the Hong Kong Stock Exchange in 2024.
Q.What are PAI Partners’ operational priorities for Elemis?
What are PAI Partners’ operational priorities for Elemis?
PAI Partners plans to expand the brand's digital commerce and push further into the United States while retaining its British positioning. The firm also intends to pivot distribution towards standalone retail and online channels across Western markets.
Q.What was the original acquisition price, and when will the sale close?
What was the original acquisition price, and when will the sale close?
L’Occitane acquired Elemis for USD 900 million in 2019 in the largest takeover in the group's history. The financial terms for the sale to PAI Partners remain undisclosed, with completion scheduled for the first quarter of 2027 subject to regulatory approvals.
Reader pulse
Was L’Occitane right to sell Elemis?
16,973 votes so far